2018³â Çѱ¹ÀÇÇÐ³í¹®µ¥ÀÌÅͺ£À̽º ±âÃÊÀÇÇÐ ¿¬±¸µ¿Ç⠺м® Å°¿öµå¸Ê Ŭ·¯½ºÆ®¸µºÐ¼®
¡à ºÐ¼®ÀÇ °³¿ä
2018³â Çѱ¹ÀÇÇÐ³í¹®µ¥ÀÌÅͺ£À̽º ±âÃÊÀÇÇÐ ¿¬±¸µ¿Ç⠺м®Àº µ¿½Ã ÃâÇö Å°¿öµå¸Ê°ú Áö½ÄÁöµµ Ŭ·¯½ºÆ®¸µ ºÐ¼®¸ÊÀ» ±¸ÇöÇÏ¿© ÀÌ·ç¾îÁ³´Ù. ÀÚ·á´Â Çѱ¹ÀÇÇÐ³í¹®µ¥ÀÌÅͺ£À̽º(KMbase)ÀÇ 2018³â Çѱ¹ÀÇÇÐ³í¹®µ¥ÀÌÅͺ£À̽º(KMbase) ¼ÁöÁ¤º¸´Â Çѱ¹ÀÎ ¿¬±¸ÀÚ°¡ ±Ø³» ¹ßÇ¥ ¹× ±¹¿Ü¹ßÇ¥, ¹Ì±¹±¹¸³º¸°Ç¿ø(National Institute of Health)ÀÇ ±¹¸³ÀÇÇеµ¼°üÀÎ PubMed¿¡ À妽ºµÈ Çѱ¹ÀÎ ¿¬±¸ÀÚ ³í¹®Á¤º¸ ÃÑ 13,3571°ÇÀ» ¼öÁý ºÐ·ùÇÏ¿© ÀÓ»óÀÇÇÐ, ±âÃÊÀÇÇÐ, ¿¹¹æÀÇÇÐ/º¸°ÇÇÐ, °£È£ÇÐ, Ä¡ÀÇÇÐ µî ÁÖ¿ä ÀÇ°úÇÐ Çй®ºÐ¾ßº°·Î Å°¿öµå ¸Ê°ú Ŭ·¯½ºÅ͸µ Áö½ÄÁöµµ ³»Æ®¿öÅ© ºÐ¼®À» ½Ç½ÃÇÏ¿´´Ù.
ÀÇ°úÇкоßÀÇ 2018³â ¿¬±¸µ¿ÇâÀ» ÆľÇÇϱâ À§ÇØ ºÐ¼®¿¡¼´Â ÀÇ°úÇבּ¸Á¤º¸¼¾ÅÍ(MedDRIC) DB¿¡¼ ÀúÀÚÅ°¿öµå(¿µ¹®)¸¦ ÃßÃâ, À¯»ç¾î ¹× µ¿ÀǾî Á¤Á¦ °úÁ¤À» °ÅÃÄ ºÐ¾ßº° ÇÙ½É Å°¿öµå¸¦ ¼±Á¤ÇÏ¿´´Ù. ÇÙ½É Å°¿öµåÀÇ ³í¹® µ¿½ÃÃâÇö µ¥ÀÌÅ͸¦ È°¿ëÇÏ¿© VOSviewer¸¦ ÅëÇØ ¸ÅÇÎ(mapping) ¹× Ŭ·¯½ºÅ͸µ(clustering) ºÐ¼®À» ¼öÇàÇÏ°í °¡½ÃÈ ÇÏ¿´À¸¸ç, Ŭ·¯½ºÅ͸µ ºÐ¼®°á°ú¿¡ µû¸¥ ¿¬±¸ ÅäÇÈ °£ÀÇ µ¿½ÃÃâÇö °ü°è´Â Gephi¸¦ ÅëÇØ °¡½ÃÈÇÏ¿´À¸¸ç, KISTIÀÇ ¹Ì·¡±â¼úºÐ¼®¼¾ÅÍ ¹ÚÁø¼ ¹Ú»çÆÀ°ú Çù¾÷À» ÅëÇÏ¿© ÀÌ·ç¾îÁ³´Ù. ºÐ¼®¿¡¼ Á¦¿Ü ½Ãų ¿ë¾î(exclusion list) ÃßÃâ°ú Å°¿öµå Á¤Á¦°úÁ¤À» ÅëÇÏ¿© ´Üº¹¼ö, µ¿ÀǾî, À¯»ç¾î word-bagÀ» »ý¼ºÇÏ¿´À¸¸ç, Àü¹®°¡ °ËÅ並 ÅëÇÏ¿© Å°¿öµå µ¿½ÃÃâÇö¸Ê°ú Áö½ÄÁöµµ ¿¬±¸µ¿Çâ Å©·¯½ºÆ®¸µ ³×Æ®¿öÅ©¸¦ ÀÛ¼ºÇÏ¿´´Ù.
´Üº¹¼ö, µ¿ÀǾî, À¯»ç¾î µî¿¡ ´ëÇÑ Á¤Á¦ °úÁ¤À» °ÅÃÄ ÃÖÁ¾ ÀúÀÚÅ°¿öµå(¿µ¹®)´Â 71,034°³·Î ³ªÅ¸³µ´Ù. ÀÌ °úÁ¤¿¡¼ Áö³ 2017³â Çѱ¹ÀÇÇÐ³í¹®(KMbase) ¿¬±¸µ¿Ç⠺м® ÀÛ¾÷À» ÅëÇØ ±¸ÃàÇÏ¿´´ø À¯ÀÇ¾î »çÀü 102°ÇÀÌ È°¿ëµÇ¾ú°í, À̹ø 2018³â ½Å±Ô ÀÛ¾÷À» ÅëÇÏ¿© 547°ÇÀÇ À¯ÀÇ¾î »çÀüÀ» »õ·Ó°Ô Ãß°¡ ±¸ÃàÇÏ¿´´Ù. ºÐ¼®µ¥ÀÌÅÍ´Â KMbase 2018³â Çмú³í¹®Àº Àüü 46,006°Ç Áß Á¤Á¦°úÁ¤À» °ÅÃÄ 44,249ÆíÀ̾úÀ¸¸ç, ÀÌÁß ±âÃÊÀÇÇÐ ºÐ¾ßº° ³í¹® °Ç¼ö´Â 13,658Æí(30.86%)À» Â÷ÁöÇÏ¿´´Ù.
Çѱ¹ÀÇÇÐ ³í¹®µ¥ÀÌÅͺ£À̽º(KMbase) ±âÃÊÀÇÇÐ Top 10 Å°¿öµå µ¿½ÃÃâÇö
|
ºóµµ
|
apoptosis
|
214
|
Inflammasome/Inflammation
|
170
|
Antioxidant (activity/capacity/effect/enzyme/properties)
|
132
|
Oxidative stress
|
128
|
Cell adhesion/cycle/death/differentiation/migration/proliferation/signaling/theraphy/viability et al.
|
113
|
Biological Markers/Biomarker/Biological therapy/Genetics
|
99
|
Autophagy
|
98
|
Cancer/Neoplasms/Carcinoma
|
94
|
Anti-inflammation (agents/effect)
|
85
|
Mesenchymal Stem Cells
|
78
|
±×¸² 1) 2018³â Çѱ¹ÀÇÇÐ³í¹®µ¥ÀÌÅͺ£À̽º(KMbase) ±âÃÊÀÇÇÐ Å°¿öµå µ¿½ÃÃâÇö ¸Ê
±×¸² 2) 2018³â Çѱ¹ÀÇÇÐ³í¹®µ¥ÀÌÅͺ£À̽º(KMbase) ±âÃÊÀÇÇÐºÐ¾ß Å¬·¯½ºÆ®¸µ ³×Æ®¿öÅ© ºÐ¼®